Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 22 papers were listed this time. Here's a handful:
Pinto AM, Kuppermann M, Nakagawa S, et al. Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res. 2011 Apr 3. [Epub ahead of print] PubMed PMID:21461953.
Purmonen TT, Pänkäläinen E, Turunen JH, et al. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial. Acta Oncol. 2011 Apr;50(3):344-52. Epub 2011 Feb 8. PubMed PMID: 21299447.
Furiak NM, Ascher-Svanum H, Klein RW, et al. Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model. Curr Med Res Opin. 2011 Apr;27(4):713-30. Epub 2011 Jan 25. PubMed PMID: 21265593.
Klersy C, De Silvestri A, Gabutti G, et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011 Apr;13(4):450-9. Epub 2010 Dec 29. PubMed PMID: 21193439.
Anis AH, Bansback N, Sizto S, et al. Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States. J Dermatolog Treat. 2011 Apr;22(2):65-74. Epub 2010 May 5. PubMed PMID: 20443663.
